Works matching IS 03009564 AND DT 2023 AND VI 130 AND IP 8
Results: 9
Drug repurposing and new drug targets: perspectives for novel treatment options in mental health disorders.
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 987, doi. 10.1007/s00702-023-02671-0
- By:
- Publication type:
- Article
The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder.
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 1057, doi. 10.1007/s00702-023-02648-z
- By:
- Publication type:
- Article
Neurobiological mechanisms of dialectical behavior therapy and Morita therapy, two psychotherapies inspired by Zen.
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 1077, doi. 10.1007/s00702-023-02644-3
- By:
- Publication type:
- Article
Plasma concentrations of anti-inflammatory cytokine TGF-β are associated with hippocampal structure related to explicit memory performance in older adults.
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 989, doi. 10.1007/s00702-023-02638-1
- By:
- Publication type:
- Article
Pathomechanisms of depression in progressive supranuclear palsy.
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 1049, doi. 10.1007/s00702-023-02621-w
- By:
- Publication type:
- Article
Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 1003, doi. 10.1007/s00702-023-02618-5
- By:
- Publication type:
- Article
Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review.
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 1029, doi. 10.1007/s00702-022-02578-2
- By:
- Publication type:
- Article
Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial.
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 1039, doi. 10.1007/s00702-022-02566-6
- By:
- Publication type:
- Article
Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice.
- Published in:
- Journal of Neural Transmission, 2023, v. 130, n. 8, p. 1013, doi. 10.1007/s00702-023-02607-8
- By:
- Publication type:
- Article